| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268768A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/02/2003 | EP1268761A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 01/02/2003 | EP1268760A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 01/02/2003 | EP1268756A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/02/2003 | EP1268753A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 01/02/2003 | EP1268750A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 01/02/2003 | EP1268748A1 Method of producing adenoviral vector stocks |
| 01/02/2003 | EP1268747A1 Detection of immunological memory, t-cell conjugates for pathology imaging and therapy |
| 01/02/2003 | EP1268746A2 PRODUCTION OF TcR GAMMA DELTA T CELLS |
| 01/02/2003 | EP1268742A2 Perfusion incubator |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268545A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268542A2 Therapeutic anti-melanoma compounds |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268536A1 Tcf responsive element |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268529A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1268516A1 Methods for detection and treatment of neural cancers |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1267944A1 Systemic gene delivery vehicles for the treatment of tumors |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267924A2 Immunotherapeutic methods and compositions |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267897A1 Treatment of congestive heart failure by pretreated autologous blood |
| 01/02/2003 | EP1267834A1 Cationic liposomes |
| 01/02/2003 | EP1267627A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof |
| 01/02/2003 | EP1267616A1 Methods of modulating hair growth |
| 01/02/2003 | EP1234026A4 Method and apparatus for selectively targeting specific cells within a cell population |
| 01/02/2003 | EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/02/2003 | EP0885007B1 Method for separating cells, especially platelets, and bag assembly therefor |
| 01/02/2003 | EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 01/02/2003 | EP0628074B1 In vitro activation of cytotoxic t cells |
| 01/02/2003 | EP0605428B9 Hormone-secreting pancreatic cells maintained in long-term culture |
| 01/01/2003 | CN1388245A Method of raising taxol yield of south taxad |
| 12/31/2002 | US6501007 Inhibiting expression of an rna transcription product of the d1 gene of given sequence using an antisense oligonucleotide; controlling daikoku type dwarfism gene d1 expression |
| 12/31/2002 | US6501005 DNA sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500939 Human homologue of the rat protein translocation protein sec61-alpha subunit, which plays a role in protein transport across the endoplasmic reticulum; use as probes for the gene diagnosis, gene sources for gene therapy and drug screening |
| 12/31/2002 | US6500934 Bivalent agonists for G-protein coupled receptors |
| 12/31/2002 | US6500932 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
| 12/31/2002 | US6500929 Protein containing a functional domain of a water-soluble c1 inhibitor and an anchor molecule; suppressing complement activity; membrane bound complement regulatory proteins; transplantation |
| 12/31/2002 | US6500922 Native polypeptide factors that are capable of association with the intracellular domain of tnf-r2 and participate in the intracellular post-receptor signaling of tnf biological activities |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/31/2002 | US6500854 Chondrongenesis promotors and indolin-2-one derivatives |
| 12/31/2002 | US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications |
| 12/31/2002 | US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor |
| 12/31/2002 | US6500668 Culture medium for avian embryonic cells |
| 12/31/2002 | US6500667 Reducing cellular production of amyloid beta from amyloid precursor protein, transforming or transfecting cells in vitro with an anti-sense reagent capable of reducing asp2 polypeptide by reducing asp2 transcription or translation |
| 12/31/2002 | US6500664 Growth differentiation factor-8 family nucleic acid sequences |
| 12/31/2002 | US6500663 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500654 Cardiac-related ankyrin-repeat protein kinase |
| 12/31/2002 | US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor |
| 12/31/2002 | US6500639 DNA shuffling to produce nucleic acids for mycotoxin detoxification |
| 12/31/2002 | US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor |
| 12/31/2002 | US6500626 Combining in aqueous binding conditions an agent, a bax polypeptide capable of binding to a bcl-2 polypeptide under the aqueous binding conditions, a bcl-2 polypeptide capable of binding to a bax polypeptide under the aqueous binding |
| 12/31/2002 | US6500624 Kainate-binding, human CNS receptors of the EAA3 family |
| 12/31/2002 | US6500617 Recombining plurality of nucleic acids comprising segments derived from a gene that confers resistance to pests such as insects producing a library; expressing encoded polypeptides and assaying |
| 12/31/2002 | US6500616 Obtaining molecular markers to identify genomic polymorphisms arising during in vitro tissue culture of propagated plants; representational difference analysis producing nucleic acid difference sequences between normal and off-type plants |
| 12/31/2002 | US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof |
| 12/31/2002 | US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3) |
| 12/31/2002 | US6500419 Method for introducing and expressing RNA in animal cells |
| 12/31/2002 | US6500211 Hybrid hydrolase enzymes |
| 12/31/2002 | CA2163614C Method of producing a taxane-type diterpene |
| 12/31/2002 | CA2153986C A method of producing a taxane-type diterpene and method of obtaining cultured cells which produce the taxane-type diterpene at a high rate |
| 12/27/2002 | WO2002103361A1 Method for identification of agents for the treatment of diabetes |
| 12/27/2002 | WO2002103350A1 Methods for cloning mammals using remodeling factors |
| 12/27/2002 | WO2002103033A1 Method of detecting and separating undifferentiated liver cellss using dlk |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002103016A2 Human tachykinin-related splice variants and compositions thereof |
| 12/27/2002 | WO2002102998A1 Animal with gene hypoexpression |
| 12/27/2002 | WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | WO2002102995A1 A novel microorganism of serratia family, isolation method and the preparation method of lignin lyases using this |
| 12/27/2002 | WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | WO2002102989A2 Method for neural stem cell differentiation using valproate |
| 12/27/2002 | WO2002102988A2 Method for neural stem cell differentiation using 5ht-1a agonists |
| 12/27/2002 | WO2002102986A2 Novel human transporter proteins and polynucleotides encoding the same |
| 12/27/2002 | WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102971A2 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 12/27/2002 | WO2002102968A1 Apparatus for and methods of preparing sperm |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof |
| 12/27/2002 | WO2002102837A2 Marker for identifying hematopoietic stem cells |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |